A Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy Subjects

NCT04481594 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Steatohepatitis (NASH)

Interventions

DRUG: HPN-01
DRUG: Placebo

Sponsor

Hepanova Inc.